(2S)-1-[[2,6-Dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylic acid, 1g

1-methyl-1-[3-(trifluoromethyl)phenyl]ethylamine hydrochloride, 97.0%, 5g

Zernike phase contrast kit with E-Plan phase EPLPHi 10/20/S40/S100 oil immersion IOS objectives, rotating Zernike condenser, telescope and green filter

(2-(3,5-Difluorophenyl)acetyl)-L-alanine, 97%, 100mg

Precision scale Models FX series with internal calibration, dust and water protection according to IP 65, 0.01 g, 3200 g, FZ-3000i-WP

Tert-butyl 3-amino-6-azabicyclo[3.2.1]Octane-6-carboxylate, 98%, 1g

4-Propargylthiomorpholine 1,1-Dioxide>98.0%(GC)25g

2-Methyl-1-(3-(trifluoromethyl)phenyl)propan-1-one, 97%, 5g

5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidine, 95.0%, 1g

3-chloro-N-(3-hydroxyphenyl)propanamide, 95.0%, 100mg

Ethyl 2-(2,4-dichloropyrimidin-5-yl)acetate, 98%, 250mg

1-(4-methyl-1,3-thiazol-2-yl)methanamine, 95.0%, 2.5g

2-Bromo-6-tert-butyloxy-pyridine, 97.0%, 10g